Evidence map›Paper›PMID 34480823›Full record

ArticleJournal of applied microbiology2022

Hypochlorous acid solution is a potent antiviral agent against SARS-CoV-2.

Noritoshi Hatanaka, Mayo Yasugi, Tomoko Sato, Masafumi Mukamoto, Shinji Yamasaki

Open access · hybridAbstract read
In one paragraph

Article in Journal of applied microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 39 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Review
  5. Commercially available antiseptics show highFrontiers in veterinary science · 2025
    Article
  6. Article
  7. Article
  8. International journal of molecular sciences · 2024
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Noritoshi HatanakaGraduate School of Life and Environmental Sciences, Osaka Prefecture University, Osaka, Japan.
Mayo YasugiGraduate School of Life and Environmental Sciences, Osaka Prefecture University, Osaka, Japan.
Tomoko SatoResearch Laboratory, Local Power Co., Ltd., Akita, Japan.
Masafumi MukamotoGraduate School of Life and Environmental Sciences, Osaka Prefecture University, Osaka, Japan.
Shinji YamasakiGraduate School of Life and Environmental Sciences, Osaka Prefecture University, Osaka, Japan.ORCID https://orcid.org/0000-0001-9063-2201
Osaka Prefecture University · JPJ-Power (Japan) · JP

Funding

Local Power Co. Ltd Collaborative research grant
6 · The paper itself

Abstract

aimA novel coronavirus, termed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) suddenly appeared in Wuhan, China, and has caused pandemic. In this study, we evaluated antiviral activity of purified hypochlorous acid (HClO) against coronaviruses such as SARS-CoV-2 and transmissible gastroenteritis virus (TGEV) responsible for pig diseases. MATERIALS AND

resultsIn a suspension test, 28.1 ppm HClO solution inactivated SARS-CoV-2 in phosphate-buffered saline with the reduction of 10

conclusionsIn a carrier test, 125 ppm HClO solution for 10 min incubation is adequate to inactivate 4 logs TCID SIGNIFICANCE AND IMPACT OF THE STUDY: Effectiveness of HClO solution against SARS-CoV-2 was demonstrated by both suspension and carrier tests. HClO solution inactivated SARS-CoV-2 by 5 logs TCID

Indexed as

COVID-19SARS-CoV-2AnimalsAntiviral AgentsHumansHypochlorous AcidPandemicsSwineAntiviral AgentsHypochlorous Acidantiviral activityCOVID-19hypochlorous acidSARS-CoV-2TGEV

Identifiers

PMID34480823
PMCPMC8657320
OpenAlexW3198726945

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.